Auspep
Auspep is an Australian specialty manufacturer of synthetic peptides, operating as the only TGA-registered GMP peptide manufacturer in Australia. It serves pharmaceutical, biotech, and life science research customers with custom peptide synthesis, GMP API manufacturing, and analytical services, and distributes international brands domestically.
- Company typePrivate
- Founded1987
- HeadquartersTullamarine, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Auspep does
Auspep is an Australian specialty manufacturer of synthetic peptides, founded in 1987 and headquartered in Tullamarine, Victoria, operating as the only GMP-accredited peptide manufacturer in Australia. The business runs on a two-tier model: a non-GMP catalogue and custom synthesis line for research customers (offering off-the-shelf peptides, amino acids, resins, reagents, and solvents alongside custom peptide libraries, purification, and analytical services) and a GMP manufacturing line operated through subsidiary Auspep Clinical Peptides Pty Ltd, which produces peptide APIs for clinical trials and commercial production. Core technology is solid phase peptide synthesis (SPPS) at scales from milligrams to kilograms, supported by in-house analytical capabilities including amino acid analysis, chromatography, NMR, mass spectroscopy, impurity profiling, and stability trials compliant with ICH and GMP standards.
The company generates revenue through quote-based one-time orders for custom peptides, GMP API contracts, and catalogue sales, plus fee-for-service analytical testing. It is TGA-registered (equivalent to FDA/EMEA) and ISO9001:2015 certified for non-GMP activities. Auspep also serves as the exclusive Australian distributor for four international principals — Bachem, Dojindo Molecular Technologies, Acris Antibodies, and Accurate Chemical — providing access to over 110,000 catalogue SKUs. The go-to-market is sales-led, direct B2B, restricted to bona fide registered research or manufacturing bodies, with stock products delivered within 2 working days and custom products within 5-25 working days via validated cold-chain logistics. Customer segments are R&D biotech, large multinational pharmaceutical companies, life science research organizations, and clinical trial sponsors requiring IND/DMF regulatory documentation support.
Auspep firmographics
Firmographics- Name
- Auspep
- Legal name
- Auspep
- Website
- https://auspep.com.au
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Auspep is an Australian specialty manufacturer of synthetic peptides, operating as the only TGA-registered GMP peptide manufacturer in Australia. It serves pharmaceutical, biotech, and life science research customers with custom peptide synthesis, GMP API manufacturing, and analytical services, and distributes international brands domestically.
- Ownership category
- akta.pro rank
Auspep industry classification
Industry- Product category
- Pharmaceutical Peptide Manufacturing
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Therapeutic Peptides & Protein/Peptide Biologics (HLAAAAAH)
- akta.pro secondary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where Auspep is headquartered
LocationHeadquarters
- HQ city
- Tullamarine
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Auspep business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Custom Peptide Synthesis (NON-GMP): Custom synthesis of research peptides for quantities from research up to pilot scale, with options for uncommon amino acids, modifications, and specific purity levels.
- GMP Peptide Products and Services: Manufacturing of GMP peptides as active pharmaceutical ingredients (APIs) suitable for clinical trials and commercial production. Includes documentation and regulatory support for IND/DMF filings.
- Catalogue Products: Off-the-shelf peptides, amino acids, resins, reagents, and solvents sold via catalogue.
- Analytical Services: Fee-for-service analytical testing including amino acid analysis, chromatography, mass spectroscopy, NMR, impurity profiling, stability trials, and water content testing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pricing for all products and services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Auspep product offering
Product offeringCore offering
Auspep manufactures and supplies synthetic peptides for the life science and pharmaceutical sectors, spanning non-GMP catalogue items (peptides, amino acids, resins, reagents, solvents) and custom peptide synthesis/libraries/purification, alongside TGA-registered GMP manufacturing of peptide active pharmaceutical ingredients (APIs) from clinical to commercial scale, supported by GMP-compliant analytical services and regulatory documentation support for IND and DMF filings. It also acts as the Australian distributor for international brands including Bachem, Dojindo, Acris Antibodies, and Accurate Chemical.
Product overview
Auspep is an Australian peptide manufacturer offering two main service tiers: non-GMP research products and GMP clinical manufacturing. Non-GMP offerings include catalogue products (Peptides, Amino Acids, Resins, Reagents, Solvents) alongside custom services (Custom Peptide Synthesis, Custom Peptide Libraries, Custom Peptide Purification, Custom Analytical Services). GMP services include GMP Manufacturing for clinical and commercial scale APIs, GMP Analytical Services (amino acid analysis, chromatography, mass spectroscopy, NMR, stability trials), Compliance & Regulatory Support for IND/DMF filings, and GMP API Collaborations. Additionally, Auspep distributes complementary products through agency partnerships with Accurate Chemical (60,000+ products), Acris Antibodies (50,000+ products), Bachem (peptides and biochemicals), and Dojindo Molecular Technologies (800+ products).
Differentiator
Problem solved
Functional benefit
Products and services
- Non-GMP Catalogue Peptides Off-the-shelf synthetic peptides sold by gross weight, typically dispensed in glass primary packaging with a certificate of analysis, for research and life science use.
- Amino Acids Off-the-shelf amino acids for peptide synthesis and research applications.
- Resins Off-the-shelf resins for solid phase peptide synthesis.
- Reagents Off-the-shelf reagents for peptide synthesis and laboratory research.
- Solvents Off-the-shelf solvents for peptide synthesis and laboratory use.
- Custom Peptide Synthesis Custom synthesis of peptides from research scale to pilot scale with modification options including acetylation, phosphorylation, biotinylation, succinylation, cyclisation, and fluorescent labeling; includes guaranteed sequences with mass spectral and HPLC analyses.
- Custom Peptide Libraries Custom synthesis of combinatory peptide libraries supporting epitope detection and identification of peptide antagonists; supports common and uncommon amino acids, variable sequence length, quantity specifications, and final product forms (solid phase or free compound).
- Custom Peptide Purification Purification service to recover peptides from assembly impurities using HPLC-based purification methods.
- Custom Analytical Services Non-GMP analytical testing including amino acid analysis, mass spectroscopy, NMR spectroscopy, and custom protein carrier conjugation for antisera production.
- GMP Manufacturing TGA-registered GMP peptide manufacturing from clinical scale to commercial scale using solid phase peptide synthesis, including process development and scale-up of Active Pharmaceutical Ingredients (APIs) compliant with local and international regulators.
- GMP Analytical Services GMP-compliant analytical services including amino acid analysis, analytical chromatography, impurity profiling, ion content analysis, mass spectroscopy, N-terminal protein sequencing, NMR spectroscopy, stability trials, and water content testing.
- Compliance and Regulatory Support Documentation preparation and regulatory support for IND and DMF filings, including Chemistry Manufacturing and Controls Information (CMCI) preparation for FDA approval.
- GMP API Collaborations Partnership service for confidential GMP peptide development from process development through commercial production for clinical trials and proprietary projects.
- Accurate Chemical Distributed Products Australian distribution of Accurate Chemical's catalogue including antibodies, antigens, cell separation media, complements, reagents, controls, complex carbohydrates, and ligands (nearly 60,000 entries).
- Acris Antibodies Distributed Products Australian distribution of Acris Antibodies' catalogue of over 50,000 antibodies and antigens, including the Antibody Location Service for matching customer requirements.
- Bachem Distributed Products Australian distribution of Bachem's high-quality biochemical and pharmaceutical compounds, including thousands of catalogue products (peptides, biochemicals, building blocks, immunochemicals) and over 25 generic peptide APIs.
- Dojindo Molecular Technologies Distributed Products Australian distribution of over 800 Dojindo research products used by research organisations across multiple disciplines.
Quantifiable outcome
- Peptides with impurity >0.5% are identified under GMP standards
- +1 more outcomes
Companies that use Auspep
Customer profileSegments3 records
Ideal customer profiles2 records
Auspep technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Auspep partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor.
- Dojindo Molecular TechnologiesminorAuspep distributes Dojindo products in Australia. Dojindo produces over 800 well-known products used by research organisations in many disciplines, including products developed jointly between Dojindo staff and outside researchers.
- BachemminorAuspep distributes Bachem products in Australia. Bachem is an independent, technology-based company specializing in high quality innovative biochemical and pharmaceutical compounds, offering thousands of catalogue products including peptides, biochemicals, building blocks, and immunochemicals, as well as over 25 generic peptide APIs.
- Acris AntibodiesminorAuspep distributes Acris products in Australia. Acris offers over 50,000 products (primarily antibodies and antigens) and provides services including Antibody Location Service and newsletter.
- Accurate Chemical & Scientific CorporationminorAuspep distributes Accurate Chemical products in Australia. Founded in 1974, Accurate offers nearly 60,000 entries including antibodies, antigens, cell separation media, reagents, and represents multiple international companies.
- Accurate Chemical International PartnersminorAccurate Chemical represents international companies including ALERE/AXIS SHIELD (Norway), CEDARLANE (Canada), DENKA SEIKEN CO (Japan), SANQUIN (Holland), LATOXAN (France), NOVAMED (Israel), and many others.
Scale indicators4 records
Recent moves6 records
Expansion highlights4 records
Auspep competitors and assessment
Company assessmentDirect peers
- AAPPTec: Specialty peptide synthesis company offering custom peptides, libraries, and peptidomimetics for research and preclinical use. Comparable custom SPPS capability and customer base in life science research.
- Bachem: Global market leader in peptide API manufacturing and CMO services. Direct competitor in GMP peptide manufacturing; notably Auspep already distributes Bachem products in Australia, illustrating full overlap of core capability.
- Peptide Sciences: Catalogue and custom research peptide supplier targeting academic and industrial research customers. Overlaps directly with Auspep's catalogue peptides and custom synthesis lines.
- CSBio: Peptide synthesis technology and contract manufacturer offering custom peptides, GMP manufacturing, and peptide synthesizers. Directly comparable SPPS-based service portfolio.
- AmbioPharm: US-based peptide CDMO specializing in GMP peptide API manufacturing for clinical and commercial supply. Operates at comparable scale to Auspep in custom and complex peptide synthesis.
- PolyPeptide Group: Publicly listed peptide CDMO offering custom synthesis, GMP manufacturing, and analytical services for therapeutic peptides and oligonucleotides. Directly comparable service portfolio targeting the same pharma/biotech customer base.
- CordenPharma: Global CDMO with a dedicated peptide platform spanning mg to commercial scale under GMP. Comparable end-to-end peptide API offering to pharmaceutical and biotech clients worldwide.
- Bio-Synthesis Inc: Custom peptide synthesis and antibody production services for research and clinical applications. Closely matches Auspep's research-grade and custom modification offering.
Broad incumbents
- GenScript: Large life sciences services company offering custom peptide synthesis alongside gene synthesis, protein production, and cell therapy services. Wider portfolio but meaningful peptide overlap.
- Thermo Fisher Scientific: Global life sciences leader whose peptide and custom synthesis offerings (including through Patheon CDMO) compete at the higher end of the market. Provides the broad incumbent benchmark for Auspep's GMP and analytical services.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Auspep social profiles
Digital presenceAuspep compliance and trust
Trust signalCompliance2 records
Auspep financial estimates
Financial estimateRevenue estimate
Valuation estimate
Auspep leadership team
Management profileNumber of profiles
Profiles1 record
Auspep subsidiaries and ownership
Company hierarchySubsidiaries1 record
Auspep funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Auspep M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Auspep
What does Auspep do?
Auspep manufactures and supplies synthetic peptides for the life science and pharmaceutical sectors, spanning non-GMP catalogue items (peptides, amino acids, resins, reagents, solvents) and custom peptide synthesis/libraries/purification, alongside TGA-registered GMP manufacturing of peptide active pharmaceutical ingredients (APIs) from clinical to commercial scale, supported by GMP-compliant analytical services and regulatory documentation support for IND and DMF filings. It also acts as the Australian distributor for international brands including Bachem, Dojindo, Acris Antibodies, and Accurate Chemical.
Is Auspep a public or private company?
Auspep is a private company. It is classified as unknown and is currently operating.
When was Auspep founded?
Auspep was founded in 1987. It employs 11 to 50 people.
Where is Auspep based?
Auspep is headquartered in Tullamarine, Australia, in the Oceania region.
How does Auspep make money?
Four revenue lines are on record. Custom Peptide Synthesis (NON-GMP) is the primary driver. The others are GMP Peptide Products and Services, catalogue Products and analytical Services.
Who are Auspep's main competitors?
Direct peers on record are AAPPTec, Bachem, Peptide Sciences, CSBio, AmbioPharm, PolyPeptide Group, CordenPharma and Bio-Synthesis Inc. Broad incumbents are GenScript and Thermo Fisher Scientific.
Does Auspep have an API?
No public API is recorded for Auspep.
What industry is Auspep in?
Auspep's product category is Pharmaceutical Peptide Manufacturing. Its primary akta.pro industry code is HLAAAAAH, Therapeutic Peptides & Protein/Peptide Biologics, with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325414 and its SIC code is 2836.